Constellation Pharmaceuticals

Constellation Pharmaceuticals is the first biopharmaceutical company dedicated to the development of novel therapeutics in the emerging field of Epigenetics, a new field of science which is focused on selective regulators of epigenetic function, which are critical to controlling gene expression.
Company Growth (employees)
Type
Private
HQ
Cambridge, US
Founded
2008
Size (employees)
61 (est)
Constellation Pharmaceuticals was founded in 2008 and is headquartered in Cambridge, US

Key People at Constellation Pharmaceuticals

Keith Dionne

Keith Dionne

President & Chief Executive Officer
Matthias Jaffe

Matthias Jaffe

Chief Financial Officer
Mark A. Goldsmith

Mark A. Goldsmith

Executive Chairman
James Audia

James Audia

Chief Scientific Officer
Brenda Sousa

Brenda Sousa

Vice President of Human Resources

Constellation Pharmaceuticals Office Locations

Constellation Pharmaceuticals has an office in Cambridge
Cambridge, US (HQ)
215 First St

Constellation Pharmaceuticals Metrics

Summary Metrics

Founding Date

2008

Total Funding

$209.5 m

Latest funding size

$55 m

Time since last funding

over 1 year

Investors

Constellation Pharmaceuticals's latest funding round in December 2015 was reported to be $55 m. In total, Constellation Pharmaceuticals has raised $209.5 m

Constellation Pharmaceuticals Online Presence

Constellation Pharmaceuticals Company Life

You may also be interested in